MKI67 and breast carcinoma: In a randomized, double-blind study, Decensi et al. [2] used tamoxifen in 120 women with hormone receptor positive breast cancer and observed a similar decrease in Ki-67 positivity with doses of 1, 5 and 20 mg/day for 28 days.